The paper: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00432-3/fulltext https://www.thelancet.com/journals/lancet/article/PIIS0140-6...

The paper: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00432-3/fulltext https://www.thelancet.com/journals/lancet/article/PIIS0140-6... "In the participants who received two standard doses, after the second dose, efficacy was higher in those with a longer prime-boost interval (vaccine efficacy 81·3% [95% CI 60·3–91·2] at ≥12 weeks) than in those with a short interval (vaccine efficacy 55·1% [33·0–69·9] at <6 weeks)."